BioCentury
ARTICLE | Finance

More from less

How Shire’s value could increase after spinning out its ADHD business

August 4, 2017 11:12 PM UTC

Shire plc (LSE:SHP; NASDAQ:SHPG) could increase in value while decreasing in size, but the market isn’t convinced.

Fourteen months after closing its acquisition of rare disease company Baxalta Inc., Shire is considering a flotation of its neuroscience business as part of an ongoing companywide strategic review...

BCIQ Company Profiles

Baxalta Inc.

Shire plc